Dear Residents, Families and Friends of Kirkhaven,

This notice serves to inform you regarding our facility COVID-19 status.  As of today, a total of 42 residents have recovered from COVID-19 having completed 14 days quarantine, showing no symptoms and a negative COVID-19 test result.  Two (2) residents who were hospitalized earlier in the month due to COVID-19 have plans to return to Kirkhaven in the next few days bringing the new total of those recovered from COVID-19 to 44 residents.

Currently, there are two (2) positive COVID-19 resident cases at our facility.  These residents remain under quarantine and are receiving care on our designated and secure COVID-19 area on the 5th household.  This designated area is separated from other resident rooms by existing fire doors and secured with a keypad entry.  All results from our universal resident testing this past Monday have been received and are negative for COVID-19. There have been no new resident cases identified at Kirkhaven since January 15, 2021.

One (1) nursing employee tested positive for COVID-19 on January 26th. The employee has been furloughed for 14 days and will not return to work until a negative COVID-19 result is received.  All residents (with the exception of those previously positive in the last 90 days) will be retested on Monday, February 1, 2021.

We are pleased to report that the NY State Department of Health Surveyors conducted an on-site Infection Control Focused Survey on Friday, January 22, 2021. After a full day of inspection and observation, surveyors reported zero deficient practices.  This is our fourth survey since the pandemic began, all of which have resulted in ZERO deficient practices.

We are very proud and thankful for all of our dedicated staff!  Their resilience and steadfast adherence to strict protocols truly demonstrates their resolve to protect and maintain the health and safety of our residents and their coworkers.

The second COVID-19 vaccination clinic was held on January 25, 2021.  46 staff members and 39 residents received their second dose of the vaccine and a second group of 18 staff members and 30 residents received their first dose of the vaccine.  A third vaccine clinic will be offered on February 15, 2021 at which time the second group of residents and staff will receive their second dose of the vaccine.  There have been no adverse reactions from the vaccine.  Some staff have reported minimal side effects; such as sore arm, headache, body aches, and fatigue lasting 24-48 hours.

Ongoing Infection Prevention Measures

Although we are COVID-19 free on three (3) of the four (4) households, out of an abundance of caution, all four (4) households will remain under quarantine.   All staff working these households continue to wear personal protective equipment (PPE) on the household and when providing direct care to residents.  Residents are encouraged to limit activities to their room and assigned household, wear face covering as tolerated and socially distance if they must leave their room.

Universal masking and face-shield policies remain in place – all employees must wear a surgical mask in all areas of our building and a face-shield when within 6 feet of another individual.

Residents and staff are monitored and screened for symptoms consistent with COVID-19 frequently in accordance with Federal and State regulations.  Residents are tested every 3-7 days if there has been an exposure until 14 days have passed without any new positive cases (resident or staff).

In accordance with the current NY State DOH guidance, nursing home staff working three (3) or more days per week are required to be tested for COVID-19 twice per week.  Staff working less than three days per week must be tested once per week.  Receiving the COVID-19 vaccine does not relieve residents or staff of Federal and State testing requirements.


New Disinfection Technology

We recently purchased The PURIS Air Biosecurity System which uses a solution of the natural oxidant Hypochlorous Acid (HOCL), and an Antimicrobial Solution (AMS).  This technology converts and dispenses a non-toxic solution (in the form of a dry fog filling every cubic inch of enclosed areas) that kills pathogens on all surfaces and in the air. Purus Air reaches wherever air flows, including surfaces (such as seats, textiles, cabinets, ventilation, fabrics, etc., closed desks and closets and in crevices unreachable with spray/surface wipes.)

The benefit of fogging is its relatively dry application on and around sensitive surfaces, such as high-tech electronics, and its economical use of the disinfectant fluid. The dry fog is safe for use within occupied working environments, and can be deployed without PPE.  Purus Air is approved by the Environmental Protection Agency (EPA) for use against SARS-CoV-2 (the virus that causes COVID-19.) Purus Air meets all OSHA regulations, including Bloodborne Pathogen Standards.  We will begin using this technology throughout our building next week.


Visitation Policy   

In-person visitation including hospice visits remain suspended until further notice.  End of Life (EOL) visits will be permitted in accordance with Federal and State regulations.   Zoom and FaceTime visits are available by appointment.  Please call your designated Social Worker, the House Manager or email: to schedule a virtual visit.


Thank you for your continued support and understanding as we work through the ongoing challenges of this pandemic.  Please submit questions regarding our COVID-19 status and pandemic emergency plan to